Reconstruction of mandibular continuity defects using recombinant human bone morphogenetic protein 2: a note of caution in an atmosphere of exuberance.
Bell
R Bryan
RB
Legacy Emanuel Hospital and Health Center, Oregon Health & Science University, Portland, OR, USA. bellb@hnsa1.com
Gregoire
Curtis
C
D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use*; D001861:Bone Regeneration / Q000187:drug effects*; D016025:Bone Transplantation; D006801:Humans; D008334:Mandible / Q000473:pathology* / Q000601:surgery; D011994:Recombinant Proteins / Q000627:therapeutic use*; D019651:Plastic Surgery Procedures; D016212:Transforming Growth Factor beta / Q000627:therapeutic use*
D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2